Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novo Nordisk Q2 net profit rises 17 percent
Yahoo/AP
Thursday, August 4, 2011 - 9:29am
tags:
Novo Nordisk, earnings
Santarus CEO Discusses Q2 2011 Results - Earnings Call Transcript
Seeking Alpha
Thursday, August 4, 2011 - 9:28am
tags:
Santarus, earnings
SuperGen's CEO Discusses Q2 2011 Results - Earnings Call Transcript
Seeking Alpha
Thursday, August 4, 2011 - 9:28am
tags:
Supergen, earnings
Allergan: The Unlikely Luxury Brand
CNBC
Thursday, August 4, 2011 - 9:27am
tags:
Allergan
Merck enters child vaccine partnership
Yahoo/AP
Thursday, August 4, 2011 - 9:21am
tags:
Merck, vaccines, Pfizer, India
Pfizer’s Diflucan May Cause Birth Defects, U.S. Says Q
Bloomberg
Thursday, August 4, 2011 - 9:20am
tags:
Pfizer, birth defects, Diflucan
Higher Revenues at Shire
Yahoo/Zacks.com
Thursday, August 4, 2011 - 9:19am
tags:
Shire, earnings
Street Still Underestimating J&J’s Pipeline: Citi
Barron's
Thursday, August 4, 2011 - 9:17am
tags:
JNJ, pipelines, Zytiga, Xarelto, Incivo
Ignore Pfizer's Financials for Now
Motley Fool
Thursday, August 4, 2011 - 9:16am
tags:
Pfizer, earnings
Pfizer plans OTC version of Lipitor: WSJ
Marketwatch
Thursday, August 4, 2011 - 9:15am
tags:
Pfizer, OTC, Lipitor
One doctor’s experience with drug company lunches
Fredericksburg.com, VA
Wednesday, August 3, 2011 - 12:01pm
tags:
physicians, Eli Lilly
Widely used PTSD drug fails test in combat veterans
CNBC
Wednesday, August 3, 2011 - 11:13am
tags:
Risperidone, PTSD, post traumatic stress disorder, Risperdal, Janssen Pharmaceuticals
Vectura gets new U.S. partner for copy of lung drug
Reuters
Wednesday, August 3, 2011 - 11:10am
tags:
Vectura, GSK, generics, Advair, VR315
3 Undervalued Biotechs With Buyout Potential
Seeking Alpha
Wednesday, August 3, 2011 - 11:08am
tags:
Biogen Idec, Abbott Laboratories, Elan, Adeona, Acorda Therapeutics, M&A
Does Vertex Pharmaceuticals Deserve a Higher Valuation?
Seeking Alpha
Wednesday, August 3, 2011 - 11:05am
tags:
Vertex Pharmaceuticals
Allergan Profit Rises on Sales of Botox Wrinkle Treatment, Breast Implants
Bloomberg
Wednesday, August 3, 2011 - 11:03am
tags:
Allergan, Botox, earnings
Six Pharma Rebels
Forbes
Wednesday, August 3, 2011 - 10:08am
tags:
pharma execs
MSMB Capital Offers $378 Million to Take Over Anemia-Drug Maker Amag
Bloomberg
Wednesday, August 3, 2011 - 9:41am
tags:
anemia, M&A, MSMB Capital, Amag Pharmaceuticals
MAP Pharmaceuticals gets $20M payment for FDA filing
Bizjournals.com
Wednesday, August 3, 2011 - 9:40am
tags:
FDA, MAP Pharmaceuticals, Levadex, migraines, Allergan
Eisai Declines Most in Four Months on Aricept Sales Prospects
Bloomberg
Wednesday, August 3, 2011 - 9:38am
tags:
Aricept, Eisai, Alzheimer's disease

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.